![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Wednesday, May 15, 2019 8:52:06 AM
Keep in mind when reading "expectation that the submittal of its IDE application to the FDA would take place early during the third quarter 2019" that Q3 is only about 6 weeks away from now! Animal and cadaver studies are probably well under way at this point. Also, confirmatory human studies planned to be completed by end of this year.
We are well on our way! I just hope that progress on these milestones can be reported publicly to keep our share price on an upward trajectory.
Message in reply to:
Highlights M&A
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM